Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/30132
Full metadata record
DC FieldValueLanguage
dc.contributor.authorALONSO ABAD, Ariel-
dc.contributor.authorMEYVISCH, Paul-
dc.contributor.authorVAN DER ELST, Wim-
dc.contributor.authorMOLENBERGHS, Geert-
dc.contributor.authorVERBEKE, Geert-
dc.date.accessioned2019-12-12T09:51:23Z-
dc.date.available2019-12-12T09:51:23Z-
dc.date.issued2019-
dc.identifier.citationJOURNAL OF BIOPHARMACEUTICAL STATISTICS, 29(3), p. 468-477-
dc.identifier.urihttp://hdl.handle.net/1942/30132-
dc.description.abstractSurrogate endpoints need to be statistically evaluated before they can be used as substitutes of true endpoints in clinical studies. However, even though several evaluation methods have been introduced over the last decades, the identification of good surrogate endpoints remains practically and conceptually challenging. In the present work, the question regarding the existence of a good surrogate is addressed using information-theoretic concepts, within a causal-inference framework. The methodology can help practitioners to assess, given a clinically relevant true endpoint and a treatment of interest, the chances of finding a good surrogate endpoint in the first place. The methodology focuses on binary outcomes and is illustrated using data from the Initial Glaucoma Treatment Study. Furthermore, a newly developed and user friendly R package Surrogate is provided to carry out the necessary calculations.-
dc.language.isoen-
dc.publisherTAYLOR & FRANCIS INC-
dc.rights2019 Taylor & Francis-
dc.subject.otherCausal inference-
dc.subject.otherFano’s inequality-
dc.subject.othersurrogate endpoints-
dc.titleA reflection on the possibility of finding a good surrogate-
dc.typeJournal Contribution-
dc.identifier.epage477-
dc.identifier.issue3-
dc.identifier.spage468-
dc.identifier.volume29-
local.format.pages10-
local.bibliographicCitation.jcatA1-
dc.description.notes[Alonso, Ariel; Meyvisch, Paul; Molenberghs, Geert; Verbeke, Geert] Katholieke Univ Leuven, I BioStat, Kapucijnenvoer 35, B-3000 Leuven, Belgium. [Van der Elst, Wim] Co Johnson & Johnson, Janssen Pharmaceut, Beerse, Belgium. [Meyvisch, Paul; Molenberghs, Geert; Verbeke, Geert] Univ Hasselt, I BioStat, Diepenbeek, Belgium. [Meyvisch, Paul] Galapagos NV, Mechelen, Belgium.-
local.publisher.placePHILADELPHIA-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1080/10543406.2018.1559854-
dc.identifier.isi000469139500004-
dc.identifier.eissn1520-5711-
local.provider.typePdf-
item.accessRightsOpen Access-
item.validationecoom 2020-
item.fulltextWith Fulltext-
item.contributorALONSO ABAD, Ariel-
item.contributorMEYVISCH, Paul-
item.contributorVAN DER ELST, Wim-
item.contributorMOLENBERGHS, Geert-
item.contributorVERBEKE, Geert-
item.fullcitationALONSO ABAD, Ariel; MEYVISCH, Paul; VAN DER ELST, Wim; MOLENBERGHS, Geert & VERBEKE, Geert (2019) A reflection on the possibility of finding a good surrogate. In: JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 29(3), p. 468-477.-
crisitem.journal.issn1054-3406-
crisitem.journal.eissn1520-5711-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
555b.pdfPeer-reviewed author version357.5 kBAdobe PDFView/Open
Show simple item record

WEB OF SCIENCETM
Citations

1
checked on Apr 24, 2024

Page view(s)

54
checked on Sep 7, 2022

Download(s)

20
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.